Latigo Biotherapeutics Inc.

LTGO

Healthcare|Medical - Pharmaceuticals|US

$12.60

-0.41 (-3.15%)

Financing Filings (last 12 months)

Shelf registrations / offering prospectuses — latest Aug 7, 2026 (424B4). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Trials past primary completion date but still active — data readout may be imminent.

Sep 2026

A Phase 1 Single and Multiple Ascending Dose Study of LTG-001 Administered Orally in Healthy Participants

Nov 5, 2026 · GlobeNewsWire

Nov 5, 2026 · GlobeNewsWire

Nov 3, 2026 · GlobeNewsWire

Sep 3, 2026 · GlobeNewsWire

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

Filed	Form	What it is	Links
Nov 6, 2026	SC 13G/A	Passive 5%+ stake	Document Index
Nov 5, 2026	10-Q	Quarterly report	Document Index
Nov 5, 2026	8-K	Material event	Document Index
Oct 29, 2026	SC 13G	Passive 5%+ stake	Document Index
Sep 3, 2026	10-Q	Quarterly report	Document Index
Sep 3, 2026	8-K	Material event	Document Index
Aug 18, 2026	SC 13G	Passive 5%+ stake	Document Index
Aug 17, 2026	SC 13D	Activist / 5%+ stake	Document Index
Aug 17, 2026	SC 13G	Passive 5%+ stake	Document Index
Aug 13, 2026	SC 13G	Passive 5%+ stake	Document Index
Aug 10, 2026	S-8	Employee stock plan	Document Index
Aug 10, 2026	8-K	Material event	Document Index
Aug 7, 2026	424B4	Offering prospectus	Document Index
Aug 6, 2026	EFFECT		Document Index
Aug 6, 2026	S-1MEF	IPO / offering registration	Document Index
Aug 6, 2026	CERT		Document Index
Aug 4, 2026	8-A12B		Document Index
Aug 4, 2026	S-1/A	IPO / offering registration	Document Index
Aug 3, 2026	S-1/A	IPO / offering registration	Document Index
Jul 17, 2026	S-1	IPO / offering registration	Document Index
Jun 5, 2026	DRS/A		Document Index
May 18, 2026	DRS/A		Document Index
Mar 27, 2026	DRS		Document Index
Feb 13, 2025	D		Document Index